These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 9366528)
1. Aberrant splicing of the TSG101 and FHIT genes occurs frequently in multiple malignancies and in normal tissues and mimics alterations previously described in tumours. Gayther SA; Barski P; Batley SJ; Li L; de Foy KA; Cohen SN; Ponder BA; Caldas C Oncogene; 1997 Oct; 15(17):2119-26. PubMed ID: 9366528 [TBL] [Abstract][Full Text] [Related]
2. FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance. McIver B; Grebe SK; Wang L; Hay ID; Yokomizo A; Liu W; Goellner JR; Grant CS; Smith DI; Eberhardt NL Clin Endocrinol (Oxf); 2000 Jun; 52(6):749-57. PubMed ID: 10848880 [TBL] [Abstract][Full Text] [Related]
3. TSG101 is not mutated in lung cancer but a shortened transcript is frequently expressed in small cell lung cancer. Oh Y; Proctor ML; Fan YH; Su LK; Hong WK; Fong KM; Sekido YS; Gazdar AF; Minna JD; Mao L Oncogene; 1998 Sep; 17(9):1141-8. PubMed ID: 9764824 [TBL] [Abstract][Full Text] [Related]
4. Identical variant TSG101 transcripts in soft tissue sarcomas and various non-neoplastic tissues. Willeke F; Ridder R; Bork P; Klaes R; Mechtersheimer G; Schwarzbach M; Zimmer D; Kloor M; Lehnert T; Herfarth C; von Knebel Doeberitz M Mol Carcinog; 1998 Dec; 23(4):195-200. PubMed ID: 9869447 [TBL] [Abstract][Full Text] [Related]
5. Expression of truncated FHIT transcripts in cervical cancers and in normal human cells. Matthews CP; Shera K; Kiviat N; McDougall JK Oncogene; 2001 Aug; 20(34):4665-75. PubMed ID: 11498789 [TBL] [Abstract][Full Text] [Related]
6. Absence of TSG101 transcript abnormalities in human cancers. Trink B; Pai SI; Spunt SL; Raman V; Cairns P; Jen J; Gabrielson E; Sukumar S; Sidransky D Oncogene; 1998 May; 16(21):2815-8. PubMed ID: 9652749 [TBL] [Abstract][Full Text] [Related]
7. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations. Fong KM; Biesterveld EJ; Virmani A; Wistuba I; Sekido Y; Bader SA; Ahmadian M; Ong ST; Rassool FV; Zimmerman PV; Giaccone G; Gazdar AF; Minna JD Cancer Res; 1997 Jun; 57(11):2256-67. PubMed ID: 9187130 [TBL] [Abstract][Full Text] [Related]
8. Role of TSG101 in uterine cervix cancer. O'Boyle JD; Proctor ML; Fong KM; Lin WM; Miller DS; Muller CY Gynecol Oncol; 1999 Dec; 75(3):401-5. PubMed ID: 10600297 [TBL] [Abstract][Full Text] [Related]
9. Truncated TSG101 transcripts in human leukemia and lymphoma cell lines. Hosokawa Y; Nagai E; Seto M J Cancer Res Clin Oncol; 2000 Feb; 126(2):79-84. PubMed ID: 10664246 [TBL] [Abstract][Full Text] [Related]
10. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors. Greenspan DL; Connolly DC; Wu R; Lei RY; Vogelstein JT; Kim YT; Mok JE; Muñoz N; Bosch FX; Shah K; Cho KR Cancer Res; 1997 Nov; 57(21):4692-8. PubMed ID: 9354423 [TBL] [Abstract][Full Text] [Related]
11. Aberrant splicing of FHIT transcripts in human gastric cancer cell lines. Lee SH; Kim HY; Kim TJ; Park HK; Kim WH; Woo KM; Cho MH Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):39-49. PubMed ID: 15080495 [TBL] [Abstract][Full Text] [Related]
12. [TSG101 and breast cancer: a correctly named tumor-suppressor gene?]. Bénard J; Ahomadégbé JC Bull Cancer; 1997 Dec; 84(12):1141-2. PubMed ID: 9587367 [TBL] [Abstract][Full Text] [Related]
13. Stress-induced aberrant splicing of TSG101: association to high tumor grade and p53 status in breast cancers. Turpin E; Dalle B; de Roquancourt A; Plassa LF; Marty M; Janin A; Beuzard Y; de Thé H Oncogene; 1999 Dec; 18(54):7834-7. PubMed ID: 10618725 [TBL] [Abstract][Full Text] [Related]
14. Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies. Ishii H; Vecchione A; Furukawa Y; Sutheesophon K; Han SY; Druck T; Kuroki T; Trapasso F; Nishimura M; Saito Y; Ozawa K; Croce CM; Huebner K; Furukawa Y Mol Cancer Res; 2003 Nov; 1(13):940-7. PubMed ID: 14638866 [TBL] [Abstract][Full Text] [Related]
15. Frequent abnormalities of the putative tumor suppressor gene FHIT at 3p14.2 in pancreatic carcinoma cell lines. Simon B; Bartsch D; Barth P; Prasnikar N; Münch K; Blum A; Arnold R; Göke B Cancer Res; 1998 Apr; 58(8):1583-7. PubMed ID: 9563464 [TBL] [Abstract][Full Text] [Related]
16. FHITness and cancer. Druck T; Berk L; Huebner K Oncol Res; 1998; 10(7):341-5. PubMed ID: 10063967 [TBL] [Abstract][Full Text] [Related]
17. Study of FHIT transcripts in normal and malignant breast tissue. Bièche I; Latil A; Becette V; Lidereau R Genes Chromosomes Cancer; 1998 Dec; 23(4):292-9. PubMed ID: 9824201 [TBL] [Abstract][Full Text] [Related]
18. Altered expression of the fragile histidine triad gene in primary gastric adenocarcinomas. Lee SH; Kim WH; Kim HK; Woo KM; Nam HS; Kim HS; Kim JG; Cho MH Biochem Biophys Res Commun; 2001 Jun; 284(3):850-5. PubMed ID: 11396980 [TBL] [Abstract][Full Text] [Related]
19. Aberrant transcripts of FHIT, TSG101 and PTEN/MMAC1 genes in normal peripheral mononuclear cells. Wang NM; Chang JG; Liu TC; Lin SF; Peng CT; Tsai FJ; Tsai CH Int J Oncol; 2000 Jan; 16(1):75-80. PubMed ID: 10601551 [TBL] [Abstract][Full Text] [Related]
20. Genomic architecture and transcriptional activation of the mouse and human tumor susceptibility gene TSG101: common types of shorter transcripts are true alternative splice variants. Wagner KU; Dierisseau P; Rucker EB; Robinson GW; Hennighausen L Oncogene; 1998 Nov; 17(21):2761-70. PubMed ID: 9840940 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]